根据协议条款约定,若本次合作因特定情形提前终止,生物技术公司Arcellx须向吉利德科学支付高达2.6亿美元的终止费用。该条款作为交易保护机制,旨在保障吉利德科学的权益,同时反映出双方对合作价值的共同认可。
交易文件明确规定,解约金的触发条件与终止情形直接关联,具体条款细节未完全公开。这一安排既体现了交易双方对合作稳定性的重视,也为可能出现的意外情况提供了明确的解决方案。
根据协议条款约定,若本次合作因特定情形提前终止,生物技术公司Arcellx须向吉利德科学支付高达2.6亿美元的终止费用。该条款作为交易保护机制,旨在保障吉利德科学的权益,同时反映出双方对合作价值的共同认可。
交易文件明确规定,解约金的触发条件与终止情形直接关联,具体条款细节未完全公开。这一安排既体现了交易双方对合作稳定性的重视,也为可能出现的意外情况提供了明确的解决方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.